Thoroughbred Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Thoroughbred Financial Services's JAZZ Position: Q3 2026 in Review
Thoroughbred Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 5.8% in Q3 2026, buying an estimated $96.8K and bringing the position to 7,106 shares worth $1.64M. The position accounts for 0.08% of the portfolio, ranked #211.
Thoroughbred Financial Services first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. 664 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Thoroughbred Financial Services held 7,106 shares of Jazz Pharmaceuticals worth $1.64M as of Q3 2026.
- Thoroughbred Financial Services bought 392 Jazz Pharmaceuticals shares in Q3 2026, an estimated $96.8K.
- Jazz Pharmaceuticals made up 0.08% of Thoroughbred Financial Services's portfolio in Q3 2026, its #211 holding.
- Thoroughbred Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 664 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Thoroughbred Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.